Baloxavir

DB15675InvestigationalSmall moleculePolymerase Acidic Endonuclease Inhibitors

Baloxavir is under investigation in clinical trial NCT04327791 (Combination Therapy With Baloxavir and Oseltamavir 1 for Hospitalized Patients With Influenza (The COMBO Trial 1)).

Chemical structure of Baloxavir
Mechanism
Curator reviewed
Formula / weight
C24H19F2N3O4S · 483.49 g/mol (avg)
Code names
S-033447

Resolves to

Compound
UNII4G86Y4JT3FCAS1985605-59-1
Clinical / RWD
RxNorm2197842
Structure
InChIKeyFIDLLEYNNRGVFR-CTNGQTDRSA-NSMILES[H][C@@]12COCCN1C(=O)C1=C(O)C(=O)C=CN1N2[C@@H]1C2=C(SCC3=C1C=CC(F)=C3F)C=CC=C2
Targets
P03433PA

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
14Drug interactionsStructured to mechanism, not free text
Sign in
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Baloxavir, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In